Investment Rating - The report assigns an "Accumulate" rating for the company, marking its first coverage [1]. Core Views - The company has been deeply engaged in the hearing aid sector for over a decade, establishing itself as a leading domestic player. It focuses on several high-value products and aims to enhance its research and sales resources [8][12]. - The aging population and increasing health awareness are driving industry expansion, with significant growth potential in the hearing aid market [31][34]. - The company is well-positioned for growth through technological advancements, brand development, and a dual-channel sales strategy [41][52]. Summary by Sections 1. Company Overview - The company specializes in hearing aids and has been a pioneer in the domestic market since its establishment in 2011, listing on the Beijing Stock Exchange in 2021 [11]. - It has a clear shareholding structure with experienced management, controlling 61.28% of the shares [16][18]. 2. Market Dynamics - The global hearing aid market is expected to grow significantly, driven by an increasing number of individuals with hearing disabilities and the aging population [31][34]. - In China, the hearing aid market has seen substantial growth, with a CAGR of 18.02% from 2015 to 2019, and is projected to continue expanding [34]. 3. Technological and Brand Development - The company emphasizes self-research and development, holding numerous patents and focusing on enhancing product quality and performance [41][44]. - Recent acquisitions, such as the purchase of IntriCon's hearing health business, are expected to strengthen its product offerings and market position [42][44]. 4. Financial Projections - The company forecasts a return to profitability with net profits projected at 0.06 billion, 0.17 billion, and 0.25 billion yuan for 2024, 2025, and 2026, respectively [1][53]. - The current price-to-earnings ratios are significantly higher than industry averages, indicating potential for future growth as the company stabilizes its earnings [54].
锦好医疗：深耕助听器领域十余载，打造国产龙头企业